Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc.（MDGL）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
mdgl · 股价预测 · 23 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 23 位华尔街分析师
Buy
23 位分析师
共识
评级分布
12 个月目标价
High
$964
Consensus
$731
+50.2% upside
Low
$571
Median: $679 · Last Close: $486.98
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$731.25
50.2% upside
High Target
$964
98.0%
Low Target
$571
17.3%
Current Price
$486.98
as of today
Based on analyst price targets, the MDGL stock price prediction for the next 12 months ranges from $571 to $964. The consensus MDGL price forecast of $731.25 implies 50.2% upside from the current price of $486.98.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $469.65 | ↓ 3.56% |
1-day model range: $467.05–$472.25. Peak: $472.25 (-3.56%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $609 | +25.1% |
| 2028 | $709 | +45.6% |
| 2029 | $784 | +61.0% |
| 2030 | $838 | +72.2% |
| 2031 | — | +79.9% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MDGL · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-13 | Truist Securities | Maintains | Buy→Buy |
| 2026-05-07 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2026-05-07 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-05-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-20 | B of A Securities | Maintains | Neutral→Neutral |
| 2026-01-20 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-12-19 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-12-11 | B. Riley Securities | Maintains | Buy→Buy |
| 2025-11-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-20 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Madrigal Pharmaceuticals, Inc. (MDGL) stock. Of the recent 115 rating actions, 8 were upgrades and 6 were downgrades. 23 analysts currently cover MDGL.
分析师推荐趋势
MDGL analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 4 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1.5B
↓ 50.2% YoY
Revenue Next Year
$2.2B
↑ 48.6% YoY
EPS This Year
$-6.55
EPS Next Year
$10.54
↓ 261.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast MDGL EPS of $-6.55 for the current fiscal year, based on estimates from 8 analysts. The MDGL revenue forecast is $1.5B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
MDGL 股价预测由两类独立数据源支撑：来自 23 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。MDGL 的共识目标价为 $731.25（+50.2% 上行空间），分析师共识为 Buy。
MDGL 的短期预测（明日）为 $469.65（-3.56%）。 MDGL 对 2027 年的股价预测均值为 $609。 MDGL 对 2030 年的预测区间为 $788–$889。
Madrigal Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 MDGL。MDGL 在 2027 年的整体展望偏积极，在覆盖分析师中约 87% 对应 Buy 共识。
常见问题
MDGL 预测 · 8 个问题根据 23 位华尔街分析师，MDGL 的 12 个月平均目标价为 $731.25，最高 $964.00、最低 $571.00。若有图表，中位目标价可在上方查看。相对当前价 $486.98，隐含约 +50.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.